Antibody responses to bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007

Clinical and Vaccine Immunology

Volumn 21, Issue 2, 2014, Pages 165-173

  Hallander, Hans ^a   Advani, Abdolreza ^a   Alexander, Frances ^b   Gustafsson, Lennart ^a   Ljungman, Margaretha ^a   Pratt, Catherine ^b   Hall, Ian ^b   Gorringe, Andrew R ^b  

^a Swedish Institute for Communicable Disease Control   (Sweden)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; CHILD; CHILD, PRESCHOOL; FEMALE; FIMBRIAE PROTEINS; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS VACCINE; SWEDEN; VACCINES, ACELLULAR; VACCINES, INACTIVATED; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 84893290022     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00641-13     Document Type: Article

References (31)

1. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. 2013. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 131:e1716-e1722. http://dx.doi.org/10.1542/peds.2012-3836.
2. Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH. 2013. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 131:e1047-e1052. http://dx.doi.org/10. 1542/peds.2012-1928.
3. Hallander HO, Nilsson L, Gustafsson L. 2011. Is adolescent pertussis vaccination preferable to natural booster infections? Expert Rev. Clin. Pharmacol. 4:705-711. http://dx.doi.org/10.1586/ecp.11.55.
4. Rodríguez ME, Hellwig SM, Pérez Vidakovics ML, Berbers GA, van de Winkel GJ. 2006. Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies. FEMS Immunol. Med. Microbiol. 46:39-47. http://dx.doi.org/10.1111/j.1574-695X.2005.00001.x.
5. Heck DV, Trus BL, Steven AC. 1996. Three-dimensional structure of Bordetella pertussis fimbriae. J. Struct. Biol. 116:264-269. http://dx.doi.org/10.1006/jsbi.1996.0041. (Pubitemid 26153710)
6. Mooi FR, Avest A, van der Heide HG. 1990. Structure of the Bordetella pertussis gene coding for the serotype 3 fimbrial subunit. FEMS Microbiol. Lett. 54:327-331.
7. Packard ER, Parton R, Coote JG, Fry NK. 2004. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J. Med. Microbiol. 53:355-365. http://dx.doi.org/10.1099/jmm.0.05515-0. (Pubitemid 38586500)
8. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, Martin IE. 2004. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J. Clin. Microbiol. 42:5364-5367. http://dx.doi.org/10.1128/JCM.42.11.5364-5367.2004. (Pubitemid 39506258)
9. Preston NW. 1985. Essential immunogens in human pertussis: the role of fimbriae. Dev. Biol. Stand. 61:137-141.
10. Robinson A, Ashworth LA, Irons LI. 1989. Serotyping Bordetella pertussis strains. Vaccine 7:491-494. http://dx.doi.org/10.1016/0264-410X(89)90270-3. (Pubitemid 20064258)
11. WHO Expert Committee on Biological Standardization. 1979. Thirtieth report. 1979. World Health Organ. Tech. Rep. Ser. 638:61-65.
12. Chen Q, Decker KB, Boucher PE, Hinton D, Stibitz S. 2010. Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA. Mol. Microbiol. 77:1326-1340. http://dx.doi.org/10.1111/j.1365-2958.2010.07293.x.
13. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:349-355. http://dx.doi.org/10.1056/NEJM199602083340602. (Pubitemid 26049587)
14. Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. 1997. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 350:1569-1577. http://dx.doi.org/10.1016/S0140-6736(97)06508-2. (Pubitemid 28036599)
15. Nilsson L, Rydevik G. 2010. Twelve year report. Pertussis surveillance in Sweden. Smittskyddsinstitutet, Solna, Sweden. http://www.smittskyddsinstitutet. se/upload/Publikationer/smirapport-01-2010.pdf.
16. Hallander HO, Advani A, Donnelly D, Gustafsson L, Carlsson RM. 2005. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J. Clin. Microbiol. 43:2856-2865. http://dx.doi.org/10.1128/JCM.43.6.2856-2865.2005. (Pubitemid 40827964)
17. Medical Research Council. 1956. Vaccination against whooping cough. Relation between protection in children and results of laboratory tests. Br. Med. J. 2:454-462.
18. Cherry JD, Gornbein J, Heininger U, Stehr K. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906. http://dx.doi.org/10.1016/S0264-410X(98)00226-6. (Pubitemid 28473933)
19. Meade BD, Deforest A, Edwards KM, Romani TA, Lynn F, O'Brien CH, Swartz CB, Reed GF, Deloria MA. 1995. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 96:570-575.
20. Storsaeter J, Hallander HO, Gustafsson L, Olin P. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916. http://dx.doi.org/10.1016/S0264- 410X(98)00227-8. (Pubitemid 28473934)
21. Alexander F, Matheson M, Fry NK, Labram B, Gorringe AR. 2012. Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease. Clin. Vaccine Immunol. 19:1776-1783. http://dx.doi.org/10. 1128/CVI.00355-12.
22. Hallander HO, Ljungman M, Jahnmatz M, Storsaeter J, Nilsson L, Gustafsson L. 2009. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. APMIS 117:660-671. http://dx.doi.org/10.1111/j.1600-0463.2009.02521.x.
23. Hallander HO. 1999. Microbiological and serological diagnosis of pertussis. Clin. Infect. Dis. 28(Suppl 2):S99-S106. http://dx.doi.org/10.1086/ 515056. (Pubitemid 29270377)
24. Reizenstein E, Hallander HO, Blackwelder WC, Kühn I, Ljungman M, Möllby R. 1995. Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J. Immunol. Methods 183:279-290. http://dx.doi.org/10.1016/0022-1759(95)00067-K.
25. Reed GF, Meade BD, Steinhoff MC. 1995. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 96:600-603.
26. Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC, Anderson EL, Englund JA, Pichichero ME, Deloria MA. 1995. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96:548-557.
27. Kallonen T, He Q. 2009. Bordetella pertussis strain variation and evolution postvaccination. Expert Rev. Vaccines 8:863-875. http://dx.doi.org/10. 1586/erv.09.46.
28. Litt DJ, Neal SE, Fry NK. 2009. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J. Clin. Microbiol. 47:680-688. http://dx.doi.org/10.1128/JCM.01838-08.
29. Poolman JT, Hallander HO. 2007. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev. Vaccines 6:47-56. http://dx.doi.org/10. 1586/14760584.6.1.47. (Pubitemid 46232480)
30. Heikkinen E, Xing DK, Olander RM, Hytönen J, Viljanen MK, Mertsola J, He Q. 2008. Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol. 8:162. http://dx.doi.org/10.1186/1471-2180-8-162.
31. Cherry JD, Heininger U, Richards DM, Storsaeter J, Gustafsson L, Ljungman M, Hallander HO. 2010. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin. Vaccine Immunol. 17:741-747. http://dx.doi.org/10.1128/CVI. 00469-09.